• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXHL2000091 AN2025 buparlisib Active ingredient Chemical Drugs(1) Import Drug Application 2020-05-10 杭州阿诺生物医药科技有限公司 Adlai Nortye Biopharma Co Ltd In Review 2020-05-09 view
JXHL2000092 AN2025 buparlisib Active ingredient Chemical Drugs(1) Import Drug Application 2020-05-10 杭州阿诺生物医药科技有限公司 Adlai Nortye Biopharma Co Ltd In Review 2020-05-09 view
JXHB2200105 AN2025 buparlisib Active ingredient Chemical Drugs(1) Supplementary Application 2022-07-28 view
JXHB2200104 AN2025 buparlisib Active ingredient Chemical Drugs(1) Supplementary Application 2022-07-28 view